To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. Our first job is to listen to and observe what our customers need, and meet those needs with quality products and services. While we are not currently experiencing delays due to this pandemic, we expect that we could see them as the situation evolves. Thank you for your understanding, patience and flexibility as ATCC does everything it can to help reduce the impact of the coronavirus pandemic to our valued customers.

SARS-CoV-2 External Control Kit

ATCC quality in a kit—find stability amidst a rapidly changing landscape

Learn more

Lab Work in a Pandemic

Read our recent article to explore the practices that ATCC has implemented over the past several months that have kept our workers safe.

Read now

New HCMI Models

We have expanded our collection to include patient-derived models for the esophagus, small intestine, colon, rectum, extrahepatic bile duct, and ampulla of Vater.

Explore now

Reference-quality Genomes

Read the recent article featuring Dr. Jacobs, Senior Director of Bioinformatics at ATCC, to explore ATCC’s efforts in developing a comprehensive database of reference-quality genome sequences.

Read now

EMT Reporter Models

Watch our on-demand webinar to explore the development of an EMT reporter model for breast cancer research.

Watch now

Ebola virus - National Institute of Allergy and Infectious Diseases (NIAID)

Amplify Virus Production

Need high-titer viral stocks? Watch our on-demand webinar to discover how STAT1 knockout cell lines can help.

View now

Solutions

Events

Webinars

Therapeutic Development

Human mesenchymal stem cells provide a promising technology for the treatment of acute respiratory distress syndrome, pneumonia, and acute lung injury. Incorporate these cells into your research today!

Vaccine Development

Using CRISPR/Cas9 gene-editing technology, we developed STAT1 knockout cell lines capable of producing high-titer viral stocks. Explore the use of these models in your vaccine research.

Molecular-based Assays

Explore a growing collection of BSL-1 and BSL-2 COVID-19 controls, including a heat-inactivated strain and genomic RNA prepared from the 2019-nCoV/USA-WA1/2020 strain and synthetic SARS-CoV-2 RNA.

FDA/EUA Assay Development

Determine the analytical specificity of your assays by performing cross-reactivity testing with viral, fungal, and bacterial species listed in the FDA EUA. Explore our extensive portfolio.

Primary cells

Choose from our extensive catalog of primary cells from normal and diseased lung tissue. Our collection includes airway epithelial cells, smooth muscle cells, and fibroblasts as well as supporting media and growth kits.

Immune cells

Study the interactions between SARS-CoV-2 and the immune system with human PBMCs, luciferase-labeled monocytes, NK cells, helper T cells, B cells, and cytotoxic T cells from ATCC!

ATCC employee opening a biorepository tank

Biorepository Services^SM

We’ll take care of the logistics and resources needed to keep your COVID-19 materials safe, so you can focus on what’s important—your research.

Custom Controls & Derivatives

We can design and produce external controls and derivatives in a variety of formats to help you verify, validate, and/or routinely monitor the performance of your workflow and assay.

Enhanced Authentication Initiative

ATCC is not only enriching the characterization of our biological collections by using next-generation sequencing, we are also making those data available to everyone through the ATCC Genome Portal.

ATCC Genome Portal

The ATCC Genome Portal makes it easy to find the high-quality whole-genome sequencing data needed for your research. With a free account, you can easily search, download, and analyze hundreds of high-quality genomes.

Exosomes

ATCC offers exosomes derived from well-authenticated cell lines and hTERT-immortalized mesenchymal stem cells. These extracellular vesicles can be used as standards for diagnostics development, disease marker studies, and vaccine development.